Isabella Strahan is getting candid about the side effects of her brain cancer treatment.
Michael Strahan's daughter shared that her hunger has been at an all-time low since finishing her third chemotherapy treatment for medulloblastoma, the malignant brain tumor she was diagnosed with in October.
"For the past week, I'd say, I had the biggest appetite," Isabella said in a May 21 video, "and then last week, it just dropped to zero. So, it's annoying."
And that's not the only side effect she's dealing with lately. The 19-year-old also admitted that she was experiencing some memory loss from taking a non-chemo medication that causes "rigor," an immune response to cancer therapies that can result in intense body chills.
"I'm having a sandwich that I don't remember ordering since I got this medication that makes me rigor," Isabella shared, "which makes me shake extremely and cold."
Excited for her meal nonetheless, she detailed her order, noting it contained "some turkey, cheddar cheese, bacon, pickles and lettuce."
But Isabella—whom along with twin sister Sophia, Michael shares with ex-wife Jean Muggli Strahan—is hopeful she won't have to deal with these negative effects much longer. After all, the University of Southern California student revealed she's nearing the end of her treatment.
"Tomorrow is really my last day of chemo," Isabella noted, "and then it's my last cycle, and then I'm done. It's insane."
Isabella's timeline update arrives a month after she learned her chemo rounds would be completed sooner than originally planned.
"I'll be done in May. And I can try and have a summer to feel better," she said while wiping away tears in an April 10 video. "I'm so happy 'cause I thought I'd be done at the end of July."
Isabella added, "These are happy tears. It's not even considered crying when it's happy tears."
Keep reading for more on Isabella's brain cancer journey:
Brain Cancer Diagnosis
Family Support
Radiation Therapy
First Chemotherapy Round
Emergency Skull Surgery
Special Visit
Chemotherapy Round 2
New Side Effects
Good News
Roadblock in Her Journey
For the latest breaking news updates, click here to download the E! News App
The global spend management sector is experiencing a tailwind of sorts. Indeed, the space is expected to grow at a compound annual growth rate of 10.3% by 2030, per Grand View Research, and adoption in other regions like the Middle East and North Africa (MENA) is expected to pick up as companies increasingly adopt expense management tools to get a clearer picture of where their money is going. Saudi Arabia-based Simplified Financial Solutions Company (SiFi), one such spend management platform in the MENA region, has now raised $10 million in a seed funding round to double down on its growth plans in its home market.
As pressure from Chinese competitors intensifies and the EV market stalls, major U.S. and European auto manufacturers are racing to cut the cost of producing electric vehicles so they can get to the price tags and profit margins of ICE cars. Now, a company spun out from the Swiss Federal Institute of Technology in Lausanne (EPFL), has raised $27 million in a Series B funding round to apply AI to solve that exact pain point. The company says it uses deep learning in a 3D environment, and combines data analysis with machine learning to speed up development times by up to 75% and product simulation by as much as 10 times.
Coming off of sold-out events in London, Los Angeles, and San Francisco, we're heading to Washington, D.C. for a cozy-vc-packed, evening at the Woolly Mammoth Theatre on Tuesday, June 11 in partnership with Revolution. Attendees can look forward to thought-provoking discussions, insightful perspectives, and plenty of chances to network—all while enjoying complimentary drinks and hors d'oeuvres.
The biggest news stories this morning: This tool unlocks Windows’ AI-powered Recall feature for unsupported PCs, Marvel’s “What If...?” for Apple Vision Pro looks incredible, but plays terribly, The IRS is making its free Turbo Tax alternative permanent.
Monzo has announced its 2024 financial results, revealing its first full-year pre-tax profit. The company also confirmed that it's in the early stages of expanding into the broader European market via a new base in Ireland.